← CASTLE BIOSCIENCES INC
| Annual Trend | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||
| Net Income (Loss) Attributable to Parent | ($6.4m) |
$5.3m
+182.88%
|
($10.3m)
-294.88%
|
($31.3m)
-204.28%
|
($67.1m)
-114.55%
|
($57.5m)
+14.41%
|
$18.2m
+131.75%
|
($24.2m)
-232.41%
|
— | |
| Net Income (Loss) Available to Common Stockholders, Basic | ($10.2m) |
$3.0m
+129.43%
|
($10.3m)
-443.83%
|
— | — | — | — | — | — | |
| Depreciation, Depletion and Amortization | $287k | $354k | $472k | $3.4m | $10.5m | $12.3m | $16.0m | $40.8m | $15.6m | |
| Depreciation | $287k | $354k | $472k | $1.4m | $2.3m | $3.3m | $4.9m | $5.9m | $5.9m | |
| Amortization of Debt Issuance Costs and Discounts | $566k | $1.9m | $839k | $0 | — | — | — | — | — | |
| Amortization of Intangible Assets | $36k | $4k | $0 | $2.0m | $8.3m | $9.0m | $11.1m | $34.8m | — | |
| Deferred Income Tax Expense (Benefit) | $0 | $0 | $0 | ($8.7m) | ($1.9m) | ($223k) | $1.4m | ($6.2m) | ($804k) | |
| Share-based Payment Arrangement, Noncash Expense | $294k | $1.2m | $8.3m | $21.7m | $36.3m | $51.2m | $50.3m | $45.9m | $44.9m | |
| Payment, Tax Withholding, Share-based Payment Arrangement | — | — | — | $781k | $1.7m | $5.1m | $8.8m | $11.7m | — | |
| Share-based Payment Arrangement, Expense | $294k | $1.2m | $8.3m | $21.7m | $36.3m | $51.2m | $50.3m | $45.9m | $44.9m | |
| Goodwill, Impairment Loss | — | — | — | — | $0 | $0 | — | — | — | |
| Other Nonoperating Income (Expense) | ($272k) | ($2.9m) | $0 | — | — | — | — | $144k | — | |
| Changes in operating assets and liabilities: | ||||||||||
| Increase (Decrease) in Accounts Receivable | $8.4m | $896k | ($1.7m) | $4.6m | $6.2m | $14.9m | $12.6m | ($6.9m) | $3.4m | |
| Increase (Decrease) in Inventories | $578k | $355k | $980k | ($327k) | $1.7m | $4.0m | $193k | $2.1m | ($2.2m) | |
| Increase (Decrease) in Accounts Payable | $197k | $557k | $169k | ($182k) | $582k | $5.7m | ($4.4m) | $3.1m | $2.3m | |
| Other Operating Income (Expense), Net | — | — | $1.9m | $0 | — | — | — | — | — | |
| Net Cash Provided by (Used in) Operating Activities | ($12.3m) |
$7.0m
+157.06%
|
$9.9m
+40.63%
|
($19.0m)
-292.43%
|
($41.7m)
-119.43%
|
($5.6m)
+86.49%
|
$64.9m
+1252.97%
|
$64.3m
-0.80%
|
$42.6m
-33.74%
|
|
| Cash flows from investing activities: | ||||||||||
| Payments to Acquire Property, Plant, and Equipment | $277k | $937k | $4.8m | $3.5m | $5.6m | $13.6m | $28.3m | $36.0m | ($43.1m) | |
| Debt Securities, Available-for-sale, Realized Gain (Loss) | — | — | — | — | $0 | $0 | $0 | — | — | |
| Debt Securities, Realized Gain (Loss) | — | — | — | — | — | — | — | $0 | — | |
| Payments to Acquire Businesses, Net of Cash Acquired | — | — | — | — | $27.0m | $0 | $0 | — | ($1k) | |
| Net Cash Provided by (Used in) Investing Activities | ($277k) | ($937k) | ($4.7m) | ($66.7m) | ($166.5m) | ($16.2m) | ($50.1m) | ($60.4m) | ($51.3m) | |
| Cash flows from financing activities: | ||||||||||
| Gain (Loss) on Extinguishment of Debt | $0 | $5.2m | ($1.4m) | $0 | — | — | — | — | — | |
| Proceeds from Issuance of Common Stock | $38k | $1.2m | $330.0m | $0 | $833k | $269k | $2.0m | $2.2m | — | |
| Net Cash Provided by (Used in) Financing Activities | $15.8m |
$88.3m
+457.41%
|
$305.9m
+246.47%
|
$5.4m
-98.23%
|
$1.5m
-72.05%
|
($2.3m)
-251.68%
|
$6.1m
+367.15%
|
($7.0m)
-213.37%
|
($11.4m)
-64.18%
|
|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $3.3m | $94.4m | $311.0m | ($80.2m) | ($206.7m) | ($24.1m) | $20.9m | ($3.0m) | $62.1m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $4.5m | $98.8m | $409.9m | $329.6m | $122.9m | $98.8m | $119.7m | $116.7m | $62.1m | |
| Additional Supplementary Disclosures | ||||||||||
| Additional Supplementary Disclosures | ||||||||||
| Proceeds from Stock Options Exercised | $38k | $1.2m | $1.6m | $4.2m | $833k | $269k | $2.0m | $2.2m | — | |
| Supplemental disclosure of cash flow information: | ||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $1.6m | $2.2m | $2.0m | $1k | $16k | $11k | $434k | $59k | — | |
| Income Taxes Paid, Net | $160k | ($150k) | $102k | $16k | $120k | $198k | $2.5m | $1.6m | — | |
| Additional Financial Items | ||||||||||
| Asset Acquisition Contingent Consideration Liability | — | — | $0 | $18.3m | $0 | $0 | $0 | $2.5m | — | |
| Equity Securities, FV-NI, Gain (Loss) | — | — | — | — | — | — | — | $1.5m | — | |
| Equity Securities, FV-NI, Realized Gain (Loss) | — | — | — | — | — | — | — | $484k | — | |
| Equity Securities, FV-NI, Unrealized Gain (Loss) | — | — | — | — | — | — | $555k | $982k | — | |
| Fair Value, Option, Changes in Fair Value, Gain (Loss) | $0 | ($2.1m) | $0 | — | — | — | — | — | — | |
| Goodwill | — | — | — | — | $10.7m | $10.7m | $10.7m | $10.7m | — | |
| Income Tax Expense (Benefit) | $9k | $72k | $84k | ($8.7m) | ($1.8m) | $101k | $3.3m | ($5.4m) | — | |
| Interest Expense Nonoperating | — | — | — | — | — | — | $577k | $86k | — | |
| Investment Income, Interest | $24k | $312k | $373k | $68k | $4.0m | — | $12.9m | $11.8m | — | |
| Operating Expenses | $21.3m | $37.2m | — | — | — | — | — | — | — |